Last edition
News about
CAI and Fedegari Group to Deliver Turnkey Sterilization Solutions to Pharma Manufacturers
CAI has inked a strategic partnership with Fedegari Group, a manufacturer and service provider of high-performance sterilization systems.
Strides Announces Best-Ever Financial Results for FY24
Strides Pharma Science Ltd. has published its consolidated financial results for the quarter (Q4FY24) and full year (FY24) ended March 31, 2024.
Asymchem to Operate Former Pfizer Sandwich and API Pilot Plant Manufacturing Facilities
Asymchem Laboratories Co., Ltd. has announced that it will operate the former Pfizer UK small molecule API pilot plant and part of the development laboratories through a new lease agreement between Asymchem and Discovery Park, establishing Asymchem’s first manufacturing footprint in Europe.
LabGenius Raises EUR 35 Million to Develop its ML-Driven Antibody Discovery Platform
LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, has secured EUR 35 million in Series B financing round.
Dragonfly Therapeutics Partners with Merck to Evaluate DF9001
Dragonfly Therapeutics, Inc. has entered into a clinical collaboration with Merck (known as MSD outside the US and Canada), to evaluate DF9001, Dragonfly's EGFR immune engager, in combination with Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in patients with advanced solid tumors expressing EGFR.
Valneva Names Dr. Hanneke Schuitemaker as Chief Scientific Officer
Valneva has appointed Dr. Hanneke Schuitemaker, PhD as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024.
eschbach to Showcase Industry 5.0 Software Shiftconnector at ACHEMA
eschbach will be participating at the highly anticipated ACHEMA, one of the chemical industry's premier events.
PharmaLytica 2024 to Mark a Decade of Excellence and Innovation for Pharma Manufacturing
PharmaLytica Expo has been approaching its milestone 10th edition launch, scheduled from May 30, 2024 to June 1, 2024, at HITEX, Hyderabad a prominent pharmaceutical hub in India.
Limula Secures USD 6.8 Million in Oversubscribed Seed Round
Limula has raised USD 6.8 million to take their solution for automating cell therapy manufacturing to the next stage of development.
Tower Cold Chain Announces its First Sustainability Report
Tower Cold Chain has recently published its first Sustainability Report, highlighting the company’s commitment to Environmental, Social and Governance (ESG) principles.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy